Organigram Holdings Inc. (NASDAQ:OGI) Q3 2024 Earnings Conference Call December 18, 2024 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Tim Emberg - CCO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Pablo Zuanic - Zuanic & Associates Yewon Kang - Canaccord Genuity Operator Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone ...

Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in 1986, managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent consulting to registered investment advisors. He is also the managing partner of New Cannabis Ventures, a leading provider of relevant financial information in the cannabis industry si ...

Darren415 I last wrote about Organigram (NASDAQ:OGI) here almost three months ago, calling it a great deal. The stock has increased a lot since then, rising from $1.525 to $1.86, a gain of 22%, but I still like it a lot despite outpacing the market. The New Cannabis Ventures Global Cannabis Stock Index has declined 1% since that article, and the Canadian Cannabis LP Index has dropped to a record low, falling 12%. Organigram represents 12.2% of my Beat the Global Cannabis Stock Index model portfolio that I s ...

nathanphoto/iStock via Getty Images Organigram Holdings (NASDAQ:OGI) reported Q3-2024 results Tuesday morning, which showed improvement in revenues and net loss. The company's stock has been up 33% over the last twelve months. The company holds a lead position in the Canadian cannabis markets and reported increasing revenues for Q3 from cannabis sales. The company does not have a current US entry strategy, but its international exports of cannabis flower are increasing. The company's stock price is currentl ...

Organigram (NASDAQ:OGI) stock is rising higher on Tuesday after the Canadian cannabis company released its most recent earnings report. The big news here is the company reporting C$41.06 million in revenue for its fiscal third quarter of the year. That's better than the C$39.24 million Wall Street was expecting. It's also a 25% improvement year-over-year from C$32.8 million. According to Organigram, the jump in revenue for the quarter is mainly due to increased recreational cannabis sales. This comes as the ...

Organigram Holdings Inc. (NASDAQ:OGI) Q3 2024 Earnings Conference Call August 13, 2024 8:00 AM ET Company Participants Max Schwartz - Director of Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - AGP Pablo Zuanic - Zuanic & Associates Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Keyla, and I'll be your conference operator today. At this time, I would like to w ...

█ ORGANIGRAM Q3 2024 Organigram Holdings Inc. Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") For the three and nine months ended June 30, 2024 and May 31, 2023 INTRODUCTION This Management's Discussion and Analysis dated August 13, 2024 (this "MD&A"), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the "Interim Financial Statements") of Organigram Holdings Inc. (the "Company" or "Organigram") for the three ...

Company Performance - Organigram's stock is up 16 4% in 2024, outperforming the New Cannabis Ventures Global Cannabis Stock Index which gained 6 2% [1] - The company reported a 5% decline in Q2 revenue to C$37 6 million, with adjusted EBITDA at -C$1 million, worse than the expected zero [2] - Canadian adult-use revenue rose 21% to C$33 1 million, while international revenue plunged 80% to C$2 2 million [2] - The company has C$71 4 million in cash at the end of Q2, with a tangible book value of C$289 8 million, higher than its market cap of C$237 5 million [2] Financial Outlook - Analysts revised FY24 revenue expectations to C$151 million with adjusted EBITDA of -C$1 million, down from previous estimates of C$178 million and C$13 million respectively [3] - For FY25 and FY26, analysts project revenue of C$165 million and C$188 million, with adjusted EBITDA of C$5 million and C$18 million [3] - The adjusted EBITDA margin for FY26 is projected at 9 6%, lower than the previous assumption of 15 9% [3] Market and Industry Trends - Canadian cannabis sales in April were C$428 6 million, up 4 4% year-over-year, with Quebec sales soaring 26% to C$61 6 million [4] - High taxation in Canada remains a significant issue for the cannabis industry [4] - The stock has declined 93% since its peak in early 2021 and is down 7 3% over the past year, underperforming the NCV Global Cannabis Index which gained 11 8% [5] Valuation and Strategic Moves - Organigram trades at 0 8X tangible book value, which is better than Canopy Growth and Tilray Brands [6] - British American Tobacco (BTI) is increasing its stake in Organigram at a price higher than the current market price [8] - The company could potentially be acquired, and rescheduling in the United States might boost investor sentiment [8] Portfolio and Peer Comparison - Organigram is the largest position in the model portfolio at 19%, with Village Farms at 15 4% [6] - Since April 19th, Organigram has declined 9 6%, worse than the average decline of other LPs [6]

Company Participants Conference Call Participants Operator Max Schwartz, you may begin your conference. Thank you,. Good morning, everyone, and thank you for joining us today. As a reminder, this conference call is being recorded and a recording will be available on Organigram's website 24 hours after today's call. In this call, references to fiscal 2023 are to the 13-month period from September 1, 2022 through September 30, 2023. Listeners should also be aware that the company relies on reputable third-par ...

3 Marijuana Stocks To Buy Before Federal ReformThis week marijuana stock investors continue to keep their outlook on the sector in a favorable place. The cannabis industry is always changing and being able to take advantage of any market shift because of it is crucial. By now many who invest in and trade marijuana stocks know that the level of volatile trading makes it tough to gauge trading patterns. With how unpredictable patterns can be finding a way to keep a close watch and updated on news and events i ...